Drug interaction and pharmacist

Journal of Young Pharmacists

Volumn 2, Issue 3, 2010, Pages 326-331

  Ansari, J ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Computerized screening systems; current indian scenario of drug interactions; drug interaction management; drug interactions

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ATORVASTATIN; AZATHIOPRINE; CISAPRIDE; CYTOCHROME P450; FLUINDOSTATIN; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; MERCAPTOPURINE; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PRAVASTATIN; PROCAINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROSUVASTATIN; SIMVASTATIN; VERAPAMIL; WARFARIN;

DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; GENETIC POLYMORPHISM; HUMAN; MYOPATHY; PARAMEDICAL PROFESSION; PHARMACIST; PHARMACOGENETICS; PHARMACOGENOMICS; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

EID: 77955914252     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.66807     Document Type: Review

References (22)

1. Farkas D, Shader RI, von Moltke LL, Greenblatt DJ. Mechanisms and consequences of drug-drug interactions. In: Gad SC, editor. Preclinical Development Handbook: ADME and Biopharmaceutical Properties. Philadelphia: Wiley; 2008. p. 879-917.
2. Ament PW, Bertolino JG, Liszewski JL. Clinically significant drug interactions. Am Fam Physician 2000; 61:1745-54.
3. Montan E, Barriocanal A, Isern I, Parajon T, Costa J. Multiple drug interactions-induced serotonin syndrome: A case report. J Clin Pharm Ther 2009;34:485-7.
4. MedWatch-What Is A Serious Adverse Event? Available from: http://www.fda.gov/medwatch/report/DESK/advevnt.htm [last retrieved on 2007 Sep 18].
5. Clinical Drug Use. Available from: http://www.clinicaldruguse.com/ [last retrieved on 2007 Sep 18].
6. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. JAMA 2001;286:2270-9.
7. Goldstein DB. Pharmacogenetics in the laboratory and the clinic. N Engl J Med 2003;348:553-6.
8. Drug-Interactions.com. Available from: http://www.medicine.iupui.edu/ flockhart/ [last retrieved on 2007 Sep 18].
9. Weinshilboum R. Inheritance and drug response. N Engl J Med 2003;348:529-37.
10. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 2003;348:538-49.
11. Sands CD, Chan ES, Welty TE. Revisiting the significance of warfarin protein-binding displacement interactions. Ann Pharmacother 2002;36:1642-4. Available from: http://www.theannals.com/cgi/reprint/36/10/1642 [last cited on 2010 Jan 20].
12. Chan L. Applying the knowledge of pharmacogenetics and pharmacogenomics in the management of drug interactions. Program and abstracts of The American Society of Health-System Pharmacists Midyear Clinical Meeting 2000; December 7, 2000; Las Vegas, Nevada. Abstract 3713020.
13. Palanisamy S, Arul Kumaran KS, Rajasekaran A. A study on assessment, monitoring, documentation and reporting of adverse drug reactions at a multi-specialty ertiary care teaching hospital in South India. Int J PharmTech Res 2009;4:1519-22.
14. Hazlet TK, Lee TA, Hansten PD, Horn JR. Performance of community pharmacy drug interaction software. J Am Pharm Assoc (Wash) 2001;41:200-4.
15. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, et al. Drug-drug interactions related to hospital admissions in older adults: A prospective study of 1000 patients. J Am Geriatr Soc 1996;44:944-8.
16. Orloff DG. Label changes for Simvastatin (Zocor). US Food and Drug Administration. 2002.
17. Chrischilles EA, Fulda TR, Byrns PJ, Winckler SC, Rupp MT, Chui MA. The role of pharmacy computer systems in preventing medication errors. J Am Pharm Assoc (Wash) 2002;42:439-48.
18. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002;41:343-70.
19. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002;40:567-72. (Pubitemid 34833176)
20. Ogbru O. Drug-food interactions. Clin Trends Pharm Pract 1996;10:53-60.
21. Ogbru O. Drug interactions with grapefruit juice. Drug Links 1997;1:59-60.
22. Bihari M. Drug interactions: Reducing your risk. American academy of family physician. Available from: http://www.About.com [last cited on 2000 Mar 15].